Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer
Nadia Saoudi, Javier Ros, Iosune Baraibar, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 412-412
Open Access | Times Cited: 12

Showing 12 citing articles:

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells
Bita Jafary, Mostafa Akbarzadeh-Khiavi, Hamed Farzi-Khajeh, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Colorectal Cancer Spectrum: From Subtypes and Epidemiology to Oncotherapies
Nidhi Agrawal, Sanjay Kumar Lanjhiyana, Meenakshi Jaiswal, et al.
Gastroenterology & Endoscopy (2025)
Open Access | Times Cited: 1
Gene expression profiling to uncover prognostic and therapeutic targets in colon cancer, combined with docking and dynamics studies to discover potent anticancer inhibitor
Mohammad Kashif
Computational Biology and Chemistry (2025) Vol. 115, pp. 108349-108349
Closed Access
A systematic review and network meta-analysis of RCTs: The effect of systemic immunotherapies on treatment outcomes and quality of life in patients with metastatic colorectal cancer
Yiying Zhu, Xiangwei Fu, Yonggang Dai
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
Advances in Targeted and Chemotherapeutic Strategies for Colorectal Cancer: Current Insights and Future Directions
Salique H. Shaham, Puneet Vij, Manish K. Tripathi
Biomedicines (2025) Vol. 13, Iss. 3, pp. 642-642
Open Access
Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
Gursimran Singh, Rohit Rohit, Pankaj Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Network pharmacology and AI in cancer research uncovering biomarkers and therapeutic targets for RALGDS mutations
S. Mohammed Zaidh, Hariharan Thirumalai Vengateswaran, Mohammad Habeeb, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance
Claudia C. Wahoski, Bhuminder Singh
Cancers (2024) Vol. 16, Iss. 13, pp. 2472-2472
Open Access | Times Cited: 3
Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers
Yan Fan, Yuan Meng, Xingwei Hu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma
Haiwen Li, Yang Li, Quan Yang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 6
Open Access | Times Cited: 1
EGFR-Targeted and NIR-Triggered Lipid-Polymer Hybrid Nanoparticles for Chemo-Photothermal Colorectal Tumor Therapy
Fang Fang, Y Chen, Xinming Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9689-9705
Open Access | Times Cited: 1
Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia
Milena Čavić, Neda Nikolić, Mladen Marinković, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2278-2278
Open Access
Page 1

Scroll to top